Innovative Medicines Initiative

Health technology company Vibrent Health...expands its digital health solutions business into Europe through a partnership with Remote Assessment of Disease and Relapse – Central Nervous System (RADAR-CNS). Vibrent Health will work with the Europe-led consortium on developing digital health programs featuring predictive analytics designed to monitor and help improve treatment for depression, multiple sclerosis, and epilepsy. RADAR-CNS is conducting research using a range of medical-grade sensors, such as electro-cardiograms, as well as a growing portfolio of consumer-grade sensors, including accelerometers and smartphone applications, that collect participant data from surveys and smartphone sensors.

Read More »